Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

MELOXICAM TABLETS

Awarded
SPE2DP26F9157Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F9157 to DMS Pharmaceutical Group Inc on August 27, 2026, for the procurement of Meloxicam Tablets. This award was issued as a delivery order under the broader commercial items contract SPE2DX25D9900, which was managed by the DLA Troop Support Medical Supply Chain. The total contract price is 270.00 dollars, covering the delivery of six bottles at a unit price of 45.00 dollars. The order specifies that shipment, inspection, and acceptance will occur at the destination under FOB destination terms. The overarching base administrative contract was established on April 2, 2025, and includes standard Part 12 clauses and Net 30 payment terms. This specific procurement is identified by NSN 6505015413243 and PR 7018084122, ensuring the supply of necessary medical pharmaceuticals to the Department of Defense.

General Info

Contract Value

$270

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

(2)

SPE2DX-25-D-9900 Contract/Order for Commercial Items

PDF•contract-document

SPEZDX-25-D-9900 / SPEZD-26-F-9157 Order for Supplies or Services

PDF•contract-document

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9157 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $270.00 Award Date: 08-27-2026 Delivery order under: SPE2DX25D9900 Line items: - MELOXICAM TABLETS (NSN/Part 6505015413243, PR 7018084122)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-5290
This solicitation, issued by DLA Troop Support Medical Supply Chain Pharm FSA under number SPE2DP-26-T-5290, is a request for quotations for Compound Benzoin Tincture, USP. The product is an over-the-counter topical solution for external use, containing 1000 mg of benzoin resin per 1 ml and 77 percent alcohol as an inactive ingredient. The requirement consists of two line items totaling five 16-ounce bottles. This is a fixed-price acquisition with a 20-day delivery requirement, and the items are to be delivered FOB Destination to specified locations, including sites in Germany and California. The contract includes stringent technical, safety, and quality requirements. The item is classified as a Type I (Code Q) item with a 36-month shelf life, requiring a minimum of 31 months of remaining shelf life at the time of receipt. Because the tincture is flammable and contains alcohol, it is classified as hazardous material; therefore, the contractor must provide a current Material Safety Data Sheet (MSDS) with each shipment and ensure packaging complies with 49 CFR and ICAO or IMDG regulations. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Additionally, the procurement is subject to domestic preference regulations, including the Buy American Act and the Berry Amendment, and requires compliance with cybersecurity standards for safeguarding covered defense information. Quotations must be submitted via the DIBBS system by the October 5, 2026, deadline.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
ALBENDAZOLE TABLETS
Solicitation # SPE2DP-26-T-5312
This solicitation, issued by the DLA Troop Support Medical Supply Chain on September 29, 2026, is a Request for Quotations for Albendazole Tablets, USP. The procurement consists of two separate line items: one for 2 bottles and another for 56 bottles, with each bottle containing two 200 mg tablets. The items are FDA-regulated and must meet a Type I (Code M) shelf-life requirement of 24 months, which is non-extendable. Storage requirements mandate a controlled room temperature between 20° to 25°C (68° to 77°F). This is not a small business set-aside, and quotes must be submitted via the DIBBS system by the deadline of October 5, 2026. The contract specifies destination-based inspection and acceptance, with delivery required within five days. Shipping destinations include the USS Gettysburg CG 64 at FPO AA 34091 and USALRCTR Bavaria in Germany. Packaging must be commercial and suitable for protecting contents from damage, with specific protocols for hazardous versus non-hazardous materials. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various federal and defense regulations, including requirements for safeguarding covered defense information, cybersecurity reporting, and compliance with the Buy American Act. Additionally, the government prohibits the use of additive manufacturing for any supplied parts or supplies unless specifically authorized.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
IMIDACLOPRID AND PERME
Solicitation # SPE2DP-26-T-5278
Solicitation SPE2DP-26-T-5278 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Advantage II flea and lice treatment for large dogs over 55 pounds. The required product is a fragrance-free, waterproof solution containing 9.10 percent Imidacloprid and 0.46 percent Pyriproxyfen, delivered in packages of four 2.5ml tubes. This material has no shelf-life requirement. The government is seeking one package with a required delivery date of September 29, 2026, to be delivered FOB Destination to the 0240 QM Support Company at Smith Barracks in Baumholder, Germany, within 20 days after receipt of order. Compliance with strict packaging and marking standards is mandatory, specifically MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. Because the solution is classified as a hazardous material, suppliers must submit Safety Data Sheets and Hazardous Communication Standard labels for review and approval prior to award in accordance with 29 C.F.R. 1910.1200 and Federal Standard No. 313-E. Quotes must be submitted via the DIBBS system by October 5, 2026. The contract incorporates various federal regulations, including the Buy American Act, Berry Amendment, and requirements for the safeguarding of covered defense information. Invoicing and payment shall be processed electronically through the Wide Area WorkFlow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS